Literature DB >> 11539421

Chance and necessity in the selection of nucleic acid catalysts.

J R Lorsch1, J W Szostak.   

Abstract

In Tom Stoppard's famous play [Rosencrantz and Guildenstern are Dead], the ill-fated heroes toss a coin 101 times. The first 100 times they do so the coin lands heads up. The chance of this happening is approximately 1 in 10(30), a sequence of events so rare that one might argue that it could only happen in such a delightful fiction. Similarly rare events, however, may underlie the origins of biological catalysis. What is the probability that an RNA, DNA, or protein molecule of a given random sequence will display a particular catalytic activity? The answer to this question determines whether a collection of such sequences, such as might result from prebiotic chemistry on the early earth, is extremely likely or unlikely to contain catalytically active molecules, and hence whether the origin of life itself is a virtually inevitable consequence of chemical laws or merely a bizarre fluke. The fact that a priori estimates of this probability, given by otherwise informed chemists and biologists, ranged from 10(-5) to 10(-50), inspired us to begin to address the question experimentally. As it turns out, the chance that a given random sequence RNA molecule will be able to catalyze an RNA polymerase-like phosphoryl transfer reaction is close to 1 in 10(13), rare enough, to be sure, but nevertheless in a range that is comfortably accessible by experiment. It is the purpose of this Account to describe the recent advances in combinatorial biochemistry that have made it possible for us to explore the abundance and diversity of catalysts existing in nucleic acid sequence space.

Entities:  

Keywords:  NASA Discipline Exobiology; Non-NASA Center

Mesh:

Substances:

Year:  1996        PMID: 11539421     DOI: 10.1021/ar9501378

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  23 in total

1.  A complex ligase ribozyme evolved in vitro from a group I ribozyme domain.

Authors:  L Jaeger; M C Wright; G F Joyce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Structure-function relationships of two closely related group IC3 intron ribozymes from Azoarcus and Synechococcus pre-tRNA.

Authors:  Y Ikawa; D Naito; H Shiraishi; T Inoue
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

3.  Evolution of aptamers with a new specificity and new secondary structures from an ATP aptamer.

Authors:  Zhen Huang; Jack W Szostak
Journal:  RNA       Date:  2003-12       Impact factor: 4.942

4.  Finding specific RNA motifs: function in a zeptomole world?

Authors:  Rob Knight; Michael Yarus
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

5.  Solution structure of an informationally complex high-affinity RNA aptamer to GTP.

Authors:  James M Carothers; Jonathan H Davis; James J Chou; Jack W Szostak
Journal:  RNA       Date:  2006-02-28       Impact factor: 4.942

6.  A critical assessment of the utility of protein-free splicing systems.

Authors:  Duncan J Smith; Maria M Konarska
Journal:  RNA       Date:  2008-11-24       Impact factor: 4.942

7.  Comprehensive experimental fitness landscape and evolutionary network for small RNA.

Authors:  José I Jiménez; Ramon Xulvi-Brunet; Gregory W Campbell; Rebecca Turk-MacLeod; Irene A Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

8.  In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.

Authors:  N K Vaish; P A Heaton; O Fedorova; F Eckstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

9.  RNA-peptide fusions for the in vitro selection of peptides and proteins.

Authors:  R W Roberts; J W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

10.  In vitro selection of self-cleaving RNAs with a low pH optimum.

Authors:  V K Jayasena; L Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.